Results 201 to 210 of about 67,431 (260)

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment. [PDF]

J Gastrointest Cancer
Westerdijk K, Steeghs N, van der Graaf WTA, Groen JS, van Erp NP, Hermens RPMG, Desar IME.   +6 more
europepmc   +1 more source

A high-throughput modular microfluidic platform for versatile functional assays at single-cell level. [PDF]

Microsyst Nanoeng
Shao N, Mai J, Godin B, Liu X.
europepmc   +1 more source

Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification. [PDF]

J Gastric Cancer
Song IH, Ahn S, Kim HD, Jo JH, Shin J, Ryu MH, Park YS.   +6 more
europepmc   +1 more source

Hypereosinophilic endocarditis presenting with intracardiac mass and severe mitral regurgitation: a case report of FIP1L1-PDGFRA positive myeloid neoplasm. [PDF]

Eur Heart J Case Rep
Rao NS, Biswas A, Kothari SS, Vyas P, Kanabar K.   +4 more
europepmc   +1 more source

Challenges in Conducting Quantitative Patient-Centered Benefit-Risk Assessments: A Case Study in Ph + ALL with Immature Efficacy Data. [PDF]

Ther Innov Regul Sci
Ashaye A, Thomas C, Kota V, Krucien N, Marsh K.   +4 more
europepmc   +1 more source

Targeting the Unmet Need in Gastrointestinal Stromal Tumors: A Contemporary Review of Investigational Clinical Trials and Therapeutic Landscape. [PDF]

Pharmaceuticals (Basel)
Belančić A, Prejac J, Golčić M, Adžić G, Katić A, Kocić L, Kovač Peić A, Librenjak N, Belev B, Mikolašević I, Pleština S.   +10 more
europepmc   +1 more source

Zebularine Boosts Imatinib Efficacy in Cells of Colorectal Cancer via Wnt-Survivin-P-Glycoprotein Pathway. [PDF]

J Biochem Mol Toxicol
Attia YM, Elkhoely A, Abdelwahed FM, Shouman SA, Omran MM.   +4 more
europepmc   +1 more source

Future Prospects of Imatinib in Advanced Pulmonary Hypertension Management. [PDF]

IUBMB Life
Davì F, Mangione S, Iaconis A, Genovese T, Tranchida N, Cuzzocrea S.   +5 more
europepmc   +1 more source

Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data. [PDF]

Circulation
Garry JD, Brittain EL.
europepmc   +1 more source

Emerging mechanisms of kinase inhibitor escape and clinical implications of ponatinib in advanced gastrointestinal stromal tumor. [PDF]

J Gastrointest Oncol
Shenoy S.
europepmc   +1 more source